Vulvar cancer (VC) accounts for 5% of all gynecologic cancer and the most common histological type is squamous cell carcinoma (up to 90%)
Giannini, A., Laganà, A.S., Chiantera, V., Vizza, E., Corrado, G., D’Oria, O. (2022). Personalized Treatment of Vulvar Cancer. CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY, 49(11) [10.31083/j.ceog4911242].
Personalized Treatment of Vulvar Cancer
Laganà, Antonio Simone;Chiantera, Vito;
2022-10-28
Abstract
Vulvar cancer (VC) accounts for 5% of all gynecologic cancer and the most common histological type is squamous cell carcinoma (up to 90%)
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
433 - Personalized Treatment of Vulvar Cancer.pdf
accesso aperto
Descrizione: Full text
Tipologia:
Versione Editoriale
Dimensione
190.57 kB
Formato
Adobe PDF
|
190.57 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
